20 LATEST RESOURCES (394 INDEXED)

×

Utilization of Cholinesterase Inhibitors for Alzheimer’s Disease in Canada · June 2022

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

×

Monitoring Patients with Psychotic Disorders for Clozapine-Induced Myocarditis or Cardiomyopathy · June 2022

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

×

Pharmacogenomic Testing in Depression: A 2021 Update · January 2022

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

×

Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings · December 2021

Publications (Books-Reports)

Substance Abuse and Mental Health Services Administration

×

Treatment Programs for Substance Use Disorder · June 2021

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

×

Bupropion for Major Depressive Disorder or Persistent Depressive Disorder (Dysthymia) · April 2021

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

×

Bupropion for Treatment Resistant Depression · April 2021

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

ARCHIVES UPDATED JAN2023 - TOP OF THE PAGE - SEARCH MORE RESOURCES